查看購物車
  • English
封面
市場調查報告書
商品編碼
1912608

血液儲存設備市場按產品類型、儲存方式、應用和最終用戶分類 - 全球預測 2026-2032 年

Blood Storage Equipment Market by Product Type, Storage Mode, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 195 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，血液儲存設備市場價值將達到 15.1 億美元，到 2026 年將成長到 16 億美元，到 2032 年將達到 25.8 億美元，年複合成長率為 7.95%。

關鍵市場統計數據
基準年 2025 15.1億美元
預計年份：2026年 16億美元
預測年份 2032 25.8億美元
複合年成長率 (%) 7.95%

全面介紹由臨床需求、技術創新、供應鏈變革和監管發展所驅動的血液儲存設備變革趨勢。

由於技術、監管和物流等多方面因素的共同作用，血液儲存設備的臨床和營運環境已進入持續變革時期期。醫院、血庫、診斷檢查室和研究實驗室都在應對日益複雜的溫控儲存、可追溯性和長期樣本完整性要求。低溫技術的進步、低溫運輸可視性的提升以及對合規性的日益重視，共同促使血液儲存設備成為整體醫療基礎設施規劃中的策略組成部分。

變革性的變化正在重塑血液儲存方式，包括低溫技術、自動化、遠端監控和醫療保健供應實踐的創新。

醫療機構在採購、部署和管理血液儲存設備方面正經歷多項變革，這些變革正在重塑醫療機構的運作方式。首先，數位化和遠端監控能力已超越了基本的警報系統，涵蓋了連續溫度記錄、預測性維護警報以及安全的雲端審核追蹤，這些功能有助於符合監管要求並實現快速事件回應。這種互聯互通降低了檢體污染的風險，並實現了跨多個機構的集中管理，從而提高了營運效率和臨床可靠性。

2025年美國關稅對血庫設備供應鏈、籌資策略及供應商關係的累積影響

到2025年，影響進口醫療設備的關稅措施對籌資策略、供應鏈彈性計畫和供應商談判產生了累積影響。傳統上依賴跨境採購的組織正在重新評估其對總到岸成本的考量，包括關稅風險、海關延誤和緊急庫存持有成本。採購團隊正擴大探索多源採購策略和本地服務協議，以減輕貿易政策波動可能帶來的潛在干擾。

關鍵細分市場洞察揭示了影響採購選擇和技術採用模式的產品、儲存、最終用戶和應用趨勢

細分市場層面的趨勢揭示了不同產品、儲存模式、最終用戶和應用領域中不同的採購促進因素和技術需求。產品類型分析區分了血庫儲存系統、超低溫儲存系統、血漿冷凍庫和冷藏庫，每種產品在資本密集度、維護特性和監管合規要求方面均有所不同。血庫儲存系統優先考慮吞吐量、可追溯性和快速存取工作流程，而超低溫系統則強調超低溫穩定性和專門的通訊協定。血漿冷凍庫需要均勻的溫度分佈和可靠的除霜循環，而冷藏庫優先考慮能源效率和穩定的冷卻性能之間的平衡，以滿足常規檢體儲存的需求。

美洲、歐洲、中東和非洲以及亞太地區的區域背景和挑戰對物流、法規和臨床需求產生影響。

區域趨勢對美洲、歐洲、中東和非洲以及亞太地區的設備選擇、服務模式和監管協調有顯著影響。每個地區的臨床需求模式和物流挑戰各不相同。在美洲，大規模綜合醫療系統和國家血液服務機構通常優先考慮擴充性的解決方案，這些方案需具備強大的供應商服務網路，並能與電子健康記錄系統互通性。供應鏈的韌性和零件的快速供應是常見的採購標準，而區域內的製造能力則有助於縮短關鍵子系統的前置作業時間。

血液銀行設備產業主要企業的概況和策略方向，包括其創新重點、夥伴關係關係和全球生產基地。

血液儲存設備領域的主要企業展現出清晰的策略方針，指導其市場定位和創新重點。一些供應商專注於拓展產品線，提供涵蓋冷藏儲存設備、血漿冷凍庫和低溫系統的產品組合。另一些供應商則強調在超低溫解決方案或整合數位監控服務等細分領域的領先地位。所有企業都呈現出一個通用的趨勢，即轉向全生命週期參與。製造商正在擴展其服務範圍、保固範圍、遠距離診斷和培訓項目，以在整體價值而非價格競爭力方面脫穎而出。

為產業領導者提供切實可行的建議，以增強韌性、加速智慧儲存的普及應用，並最佳化採購和資產生命週期管理。

產業領導者應推行一系列切實可行、影響深遠的舉措，以增強韌性並加速先進儲存解決方案的普及。首先，應優先建構一個採購框架，該框架應包含基於場景的總成本分析，涵蓋維護、服務回應時間和潛在的貿易政策影響。在合約中增加柔軟性，例如簽訂多年服務協議、備件寄售協議以及明確的升級流程，可以降低營運風險並支援可預測的預算編制。

調查方法概述了應用於血液儲存設備市場的資料來源、相關人員訪談、檢驗通訊協定和分析框架。

本調查方法整合了多種資料來源和系統性的檢驗通訊協定，以確保研究結果的可靠性和適用性。主要資料來源包括對採購人員、實驗室主任、醫學技師和臨床終端使用者的訪談，以了解實際操作中面臨的挑戰、選擇標準和維護經驗。二級資訊來源包括監管指南、技術標準、產品資料和同行評審文獻，以闡明性能預期和合規義務的具體情況。

總結了血液儲存設備生態系統中相關人員的策略意義、營運重點和創新路徑的結論

對臨床優先事項、技術發展和營運限制的綜合分析表明，血液儲存設備相關人員正面臨一個策略轉折點。採用具備強大遠端監控能力和服務生態系統的互操作系統的機構，將在加強合規管理、降低檢體風險和應對不斷擴展的臨床應用方面獲得優勢。同時，將產品開發與生命週期服務交付和區域支援模式結合的供應商，將實現更高的客戶維繫和更短的採用週期。

目錄

第1章：序言

第2章調查方法

  • 研究設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查前提
  • 調查限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會地圖
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章 依產品類型分類的血液儲存設備市場

  • 血庫儲存系統
  • 冷凍保存系統
  • 等離子冷凍庫
  • 冷藏庫

第9章 依保存方式分類的血液保存設備市場

  • 低溫儲存
    • 液相
    • 氣相
  • 冷凍儲存
  • 冷藏庫

第10章 血液保存設備市場：依應用領域分類

  • 血液成分保存
  • 血漿保存
  • 血小板儲存
  • 幹細胞保存

第11章 依最終用戶分類的血液儲存設備市場

  • 血庫
  • 診斷檢查室
  • 醫院
  • 研究所

第12章 血液保存設備市場：依地區分類

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第13章 血液儲存設備市場（依組別分類）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章 各國血液儲存設備市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章：美國血液儲存設備市場

第16章 中國血液儲存設備市場

第17章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Arctiko A/S
  • B Medical Systems sal
  • Binder GmbH & Co. KG
  • Haier Biomedical Co., Ltd.
  • Helmer Scientific Inc.
  • PHC Holdings Corporation
  • StemCyte Inc.
  • Stirling Ultracold, LLC
  • Terumo Corp.
  • Thermo Fisher Scientific Inc.
  • Vita 34 AG
Product Code: MRR-AE420CB13A59

The Blood Storage Equipment Market was valued at USD 1.51 billion in 2025 and is projected to grow to USD 1.60 billion in 2026, with a CAGR of 7.95%, reaching USD 2.58 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 1.51 billion
Estimated Year [2026] USD 1.60 billion
Forecast Year [2032] USD 2.58 billion
CAGR (%) 7.95%

Comprehensive introduction to the changing blood storage equipment landscape driven by clinical needs, tech innovation, supply chain shifts, and regulation

The clinical and operational landscape for blood storage equipment has entered a period of sustained transformation driven by converging technological, regulatory, and logistical pressures. Hospitals, blood banks, diagnostic laboratories, and research institutes are navigating increasingly complex requirements for temperature-controlled storage, traceability, and long-term sample integrity. Advances in cryogenic techniques, improvements in cold-chain visibility, and a stronger emphasis on compliance have combined to elevate the strategic importance of storage equipment within broader healthcare infrastructure planning.

Stakeholders now demand solutions that not only preserve biological viability but also integrate with laboratory information systems and enterprise asset management platforms. Procurement teams are balancing total cost of ownership considerations against resilience imperatives such as redundancy, maintenance frequency, and emergency power tolerance. At the same time, research institutions and specialized centers are pushing the envelope on ultra-low temperature storage capabilities to support stem cell and regenerative medicine programs. Consequently, product roadmaps and vendor selection criteria have shifted from a pure capital-equipment orientation to a lifecycle-driven dialogue that prioritizes interoperability, data integrity, and service continuity.

Transformative shifts reshaping blood storage equipment including cryogenic breakthroughs, automation, remote monitoring, and supply practices in healthcare

Several transformative shifts are reshaping how healthcare organizations source, deploy, and manage blood storage equipment. First, digitalization and remote monitoring capabilities have progressed beyond basic alarm systems to include continuous temperature logging, predictive maintenance alerts, and secure cloud-based audit trails that support regulatory compliance and rapid incident response. This interconnectivity reduces the risk of sample compromise and enables centralized oversight across multiple facilities, enhancing operational efficiency and clinical confidence.

Second, cryogenic innovation has delivered materials, insulation, and cooling system refinements that extend sample lifetimes and reduce energy consumption. Concurrently, modular design principles and automation are enabling higher-density storage with more predictable retrieval times, which is critical for high-throughput blood banks and research biobanks. Third, supply chain dynamics-including regional manufacturing footprints, component lead times, and logistics constraints-are prompting procurement teams to prioritize vendors that can demonstrate resilient distribution and local service capabilities. Finally, policy and regulatory changes have reinforced the need for validated storage solutions, harmonized QA protocols, and robust documentation to satisfy accreditation and audit demands, thereby accelerating the adoption of standardized equipment and vendor consolidation in certain segments.

Cumulative implications of United States tariff measures in 2025 on blood storage equipment supply chains, procurement strategies, and vendor relationships

In 2025, tariff actions affecting imported medical equipment have had a cumulative impact on procurement strategies, supply chain resilience planning, and vendor negotiations. Organizations that historically relied on cross-border sourcing have re-evaluated total landed cost considerations to include tariff exposure, customs delays, and contingency inventory holdings. Procurement teams have increasingly sought multi-sourcing strategies and local-service agreements to mitigate potential disruptions stemming from trade policy volatility.

These developments underline the importance of transparent cost modeling and contractual flexibility. Contract terms are evolving to include clearer escalation clauses, manufacturer-supplied service commitments, and collaborative repair networks to reduce downtime risk. For capital-intensive purchases such as cryogenic storage systems and high-performance plasma freezers, lifecycle cost analysis is now being augmented with scenario planning that models tariff-driven price variability. At the same time, partnerships between vendors and regional distributors have become more strategic, focusing on local assembly, spare-parts warehousing, and certified service technicians to preserve uptime and regulatory compliance under changing trade regimes.

Key segmentation insights revealing product, storage mode, end user, and application dynamics that influence procurement choices and technology adoption patterns

Segment-level dynamics reveal distinct procurement drivers and technology needs across product, storage mode, end user, and application lenses. Product Type analysis differentiates blood bank storage systems, cryogenic storage systems, plasma freezers, and refrigerators, each presenting different capital intensity, maintenance profiles, and regulatory validation requirements. Blood bank storage systems prioritize throughput, traceability, and rapid access workflows, whereas cryogenic systems emphasize ultra-low temperature stability and specialized handling protocols. Plasma freezers demand uniform temperature distribution and reliable defrost cycles, while refrigerators balance energy efficiency with consistent refrigeration for routine sample holdings.

Storage Mode segmentation shows that cryogenic storage, frozen storage, and refrigerated storage each impose unique infrastructure and service demands. Cryogenic Storage further divides into liquid phase and vapor phase modalities, with liquid phase offering higher thermal capacity but requiring stringent handling protocols, and vapor phase delivering safer sample isolation with different maintenance implications. Frozen storage workflows hinge on reliable freeze-thaw cycles and temperature ramp control, while refrigerated storage focuses on maintaining narrow temperature bands and minimizing thermal excursions during frequent door openings.

Looking through the End User perspective, blood banks, diagnostic laboratories, hospitals, and research institutes exhibit different procurement cadences, validation requirements, and service expectations. Blood banks often emphasize high-volume, rapid-turnover solutions that integrate with donor management systems. Diagnostic laboratories prioritize throughput and sample traceability across multiple assay platforms. Hospitals seek versatile systems that support clinical workflows across transfusion services and pathology, while research institutes require highly controlled environments suited to long-term sample integrity and specialized experiments.

Application segmentation-blood component storage, plasma storage, platelet storage, and stem cell storage-drives nuanced requirements in temperature control, container compatibility, and monitoring granularity. Blood component storage demands strict separation and labeling workflows; plasma storage needs consistent subzero temperatures and validated thawing protocols; platelet storage requires controlled agitation and near-ambient cold storage solutions; and stem cell storage pushes the limits of ultra-low temperature cryogenic solutions with an emphasis on minimal thermal fluctuation and rigorous chain-of-custody documentation. Taken together, these segmentation perspectives underscore that procurement decisions are increasingly shaped by an intersection of functional performance, integration capability, service footprint, and regulatory validation pathways.

Regional context and challenges across the Americas, Europe Middle East and Africa, and Asia-Pacific influencing logistics, regulation, and clinical demand

Regional dynamics materially influence equipment selection, service models, and regulatory alignment across the Americas, Europe Middle East and Africa, and Asia-Pacific, each presenting a distinct mix of clinical demand patterns and logistical challenges. In the Americas, large integrated healthcare systems and national blood services often prioritize scalable solutions with strong vendor service networks and interoperability with electronic health records. Supply chain resilience and rapid parts availability are common procurement criteria, and regional manufacturing capabilities can accelerate lead times for critical subsystems.

Europe Middle East and Africa encompasses highly heterogeneous regulatory environments and infrastructure maturity levels. In several European markets, stringent regulatory harmonization and accreditation standards favor validated systems with robust documentation and lifecycle support. The Middle East and Africa region displays diverse procurement models where local distributors and service partners play an outsized role, and systems that permit flexible installation and remote diagnostics are particularly valued. Across this combined region, cross-border logistics and customs processes often influence decisions around spare parts inventory and local technician training.

Asia-Pacific presents a combination of rapid capacity expansion in healthcare and variable regulatory harmonization across jurisdictions. Demand for modular, scalable systems that support high-throughput blood banks and growing research biobanks is rising. Local manufacturing and regional assembly options are increasingly important to reduce exposure to lead-time variability, while remote monitoring and tele-service capabilities address maintenance constraints in more distributed geographies. Collectively, these regional factors drive differentiated strategies for vendor selection, service contracts, and capital planning.

Profiles and strategic direction of leading companies in blood storage equipment covering innovation focus, partnerships, and global production footprints

Leading companies in the blood storage equipment space demonstrate distinct strategic approaches that signal their market positioning and innovation priorities. Some vendors concentrate on product-line breadth, offering a portfolio that spans refrigerated storage, plasma freezers, and cryogenic systems, while others emphasize niche leadership in ultra-low temperature solutions or integrated digital monitoring services. Across profiles, a common thread is a shift toward lifecycle engagement: manufacturers are expanding service offerings, warranties, remote diagnostics, and training programs to differentiate on total value rather than price alone.

Partnership models and distribution networks also reflect strategic choices. Several firms pursue direct engagement with large health systems and centralized laboratories, delivering bundled solutions that include installation, validation, and long-term service agreements. Others leverage distributor partnerships to access fragmented or emerging markets, enabling local after-sales support and faster parts provisioning. Manufacturing and production footprints are optimized to balance cost-competitive assembly with proximity to key regional markets, thereby reducing lead times and tariff exposure. In parallel, vendors increasingly collaborate with software providers and laboratory automation firms to deliver interoperable ecosystems that enhance sample traceability and support regulatory documentation requirements.

Actionable recommendations for industry leaders to boost resilience, speed smart storage adoption, and optimize procurement and asset lifecycle management

Industry leaders should pursue a set of pragmatic, high-impact actions to strengthen resilience and accelerate adoption of advanced storage solutions. First, prioritize procurement frameworks that incorporate scenario-based total cost analysis covering maintenance, service response times, and potential trade policy impacts. Embedding flexibility into contracts-such as multi-year service commitments, spare-parts consignment arrangements, and clearly defined escalation paths-reduces operational risk and supports predictable budgeting.

Second, accelerate integration of digital monitoring and predictive maintenance technologies. Deploying systems that support continuous temperature verification, automated alerting, and secure remote access can materially reduce sample loss incidents and lower maintenance costs. Third, build stronger regional service capabilities through distributor partnerships, local technician certification programs, and regional parts depots to shorten repair cycles and protect uptime. Fourth, standardize validation and documentation practices across sites to streamline audits and accreditation processes, ensuring that new equipment installations meet clinical and regulatory expectations. Finally, invest in vendor collaboration for tailored solutions-co-developed hardware-software packages, bundled training, and joint contingency planning-that align with institutional clinical priorities and enable faster adoption of high-value storage technologies.

Research methodology outlining data sources, stakeholder interviews, validation protocols, and analytical frameworks applied to blood storage equipment market

The research methodology integrates multiple data sources and structured validation protocols to ensure the reliability and applicability of insights. Primary inputs include stakeholder interviews with procurement leaders, laboratory directors, biomedical engineers, and clinical end users, capturing real-world operational challenges, selection criteria, and maintenance experiences. Secondary sources comprise regulatory guidance, technical standards, product literature, and peer-reviewed literature that contextualize performance expectations and compliance obligations.

Analytical frameworks applied in the study include qualitative trend synthesis, comparative vendor profiling, and scenario-based procurement analysis. Data validation occurs through triangulation-cross-referencing interview findings with documented performance claims and service records-and through iterative review cycles with subject-matter experts to resolve discrepancies. The approach emphasizes transparency in methodological assumptions and documents limitations where data granularity for specialized applications (such as stem cell cryopreservation protocols) varies by institution.

Conclusion synthesizing strategic implications, operational priorities, and innovation pathways for stakeholders in blood storage equipment ecosystems

The synthesis of clinical priorities, technology evolution, and operational constraints points to a strategic inflection for blood storage equipment stakeholders. Organizations that adopt interoperable systems with strong remote monitoring and service ecosystems will be better positioned to manage compliance, reduce sample risk, and support expanding clinical applications. Simultaneously, vendors that align product development with lifecycle service offerings and regional support models will improve customer retention and reduce time-to-deployment friction.

Looking ahead, the interplay between cryogenic innovation, digitalization, and supply chain resilience will drive differentiated outcomes across end users and regions. Decision-makers should therefore evaluate equipment investments not only for immediate performance but also for their capacity to integrate into broader digital and clinical workflows, support regulatory scrutiny, and withstand logistical shocks. By synthesizing these considerations into procurement and operational plans, stakeholders can enhance clinical outcomes, protect biological assets, and create a foundation for scalable laboratory and transfusion services.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Blood Storage Equipment Market, by Product Type

  • 8.1. Blood Bank Storage Systems
  • 8.2. Cryogenic Storage Systems
  • 8.3. Plasma Freezers
  • 8.4. Refrigerators

9. Blood Storage Equipment Market, by Storage Mode

  • 9.1. Cryogenic Storage
    • 9.1.1. Liquid Phase
    • 9.1.2. Vapor Phase
  • 9.2. Frozen Storage
  • 9.3. Refrigerated Storage

10. Blood Storage Equipment Market, by Application

  • 10.1. Blood Component Storage
  • 10.2. Plasma Storage
  • 10.3. Platelet Storage
  • 10.4. Stem Cell Storage

11. Blood Storage Equipment Market, by End User

  • 11.1. Blood Banks
  • 11.2. Diagnostic Laboratories
  • 11.3. Hospitals
  • 11.4. Research Institutes

12. Blood Storage Equipment Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Blood Storage Equipment Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Blood Storage Equipment Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Blood Storage Equipment Market

16. China Blood Storage Equipment Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. Arctiko A/S
  • 17.6. B Medical Systems s.a.l.
  • 17.7. Binder GmbH & Co. KG
  • 17.8. Haier Biomedical Co., Ltd.
  • 17.9. Helmer Scientific Inc.
  • 17.10. PHC Holdings Corporation
  • 17.11. StemCyte Inc.
  • 17.12. Stirling Ultracold, LLC
  • 17.13. Terumo Corp.
  • 17.14. Thermo Fisher Scientific Inc.
  • 17.15. Vita 34 AG

LIST OF FIGURES

  • FIGURE 1. GLOBAL BLOOD STORAGE EQUIPMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL BLOOD STORAGE EQUIPMENT MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL BLOOD STORAGE EQUIPMENT MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL BLOOD STORAGE EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL BLOOD STORAGE EQUIPMENT MARKET SIZE, BY STORAGE MODE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL BLOOD STORAGE EQUIPMENT MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL BLOOD STORAGE EQUIPMENT MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL BLOOD STORAGE EQUIPMENT MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL BLOOD STORAGE EQUIPMENT MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL BLOOD STORAGE EQUIPMENT MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES BLOOD STORAGE EQUIPMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA BLOOD STORAGE EQUIPMENT MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL BLOOD STORAGE EQUIPMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL BLOOD STORAGE EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL BLOOD STORAGE EQUIPMENT MARKET SIZE, BY BLOOD BANK STORAGE SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL BLOOD STORAGE EQUIPMENT MARKET SIZE, BY BLOOD BANK STORAGE SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL BLOOD STORAGE EQUIPMENT MARKET SIZE, BY BLOOD BANK STORAGE SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL BLOOD STORAGE EQUIPMENT MARKET SIZE, BY CRYOGENIC STORAGE SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL BLOOD STORAGE EQUIPMENT MARKET SIZE, BY CRYOGENIC STORAGE SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL BLOOD STORAGE EQUIPMENT MARKET SIZE, BY CRYOGENIC STORAGE SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL BLOOD STORAGE EQUIPMENT MARKET SIZE, BY PLASMA FREEZERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL BLOOD STORAGE EQUIPMENT MARKET SIZE, BY PLASMA FREEZERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL BLOOD STORAGE EQUIPMENT MARKET SIZE, BY PLASMA FREEZERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL BLOOD STORAGE EQUIPMENT MARKET SIZE, BY REFRIGERATORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL BLOOD STORAGE EQUIPMENT MARKET SIZE, BY REFRIGERATORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL BLOOD STORAGE EQUIPMENT MARKET SIZE, BY REFRIGERATORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL BLOOD STORAGE EQUIPMENT MARKET SIZE, BY STORAGE MODE, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL BLOOD STORAGE EQUIPMENT MARKET SIZE, BY CRYOGENIC STORAGE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL BLOOD STORAGE EQUIPMENT MARKET SIZE, BY CRYOGENIC STORAGE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL BLOOD STORAGE EQUIPMENT MARKET SIZE, BY CRYOGENIC STORAGE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL BLOOD STORAGE EQUIPMENT MARKET SIZE, BY CRYOGENIC STORAGE, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL BLOOD STORAGE EQUIPMENT MARKET SIZE, BY LIQUID PHASE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL BLOOD STORAGE EQUIPMENT MARKET SIZE, BY LIQUID PHASE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL BLOOD STORAGE EQUIPMENT MARKET SIZE, BY LIQUID PHASE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL BLOOD STORAGE EQUIPMENT MARKET SIZE, BY VAPOR PHASE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL BLOOD STORAGE EQUIPMENT MARKET SIZE, BY VAPOR PHASE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL BLOOD STORAGE EQUIPMENT MARKET SIZE, BY VAPOR PHASE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL BLOOD STORAGE EQUIPMENT MARKET SIZE, BY FROZEN STORAGE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL BLOOD STORAGE EQUIPMENT MARKET SIZE, BY FROZEN STORAGE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL BLOOD STORAGE EQUIPMENT MARKET SIZE, BY FROZEN STORAGE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL BLOOD STORAGE EQUIPMENT MARKET SIZE, BY REFRIGERATED STORAGE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL BLOOD STORAGE EQUIPMENT MARKET SIZE, BY REFRIGERATED STORAGE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL BLOOD STORAGE EQUIPMENT MARKET SIZE, BY REFRIGERATED STORAGE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL BLOOD STORAGE EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL BLOOD STORAGE EQUIPMENT MARKET SIZE, BY BLOOD COMPONENT STORAGE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL BLOOD STORAGE EQUIPMENT MARKET SIZE, BY BLOOD COMPONENT STORAGE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL BLOOD STORAGE EQUIPMENT MARKET SIZE, BY BLOOD COMPONENT STORAGE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL BLOOD STORAGE EQUIPMENT MARKET SIZE, BY PLASMA STORAGE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL BLOOD STORAGE EQUIPMENT MARKET SIZE, BY PLASMA STORAGE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL BLOOD STORAGE EQUIPMENT MARKET SIZE, BY PLASMA STORAGE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL BLOOD STORAGE EQUIPMENT MARKET SIZE, BY PLATELET STORAGE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL BLOOD STORAGE EQUIPMENT MARKET SIZE, BY PLATELET STORAGE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL BLOOD STORAGE EQUIPMENT MARKET SIZE, BY PLATELET STORAGE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL BLOOD STORAGE EQUIPMENT MARKET SIZE, BY STEM CELL STORAGE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL BLOOD STORAGE EQUIPMENT MARKET SIZE, BY STEM CELL STORAGE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL BLOOD STORAGE EQUIPMENT MARKET SIZE, BY STEM CELL STORAGE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL BLOOD STORAGE EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL BLOOD STORAGE EQUIPMENT MARKET SIZE, BY BLOOD BANKS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL BLOOD STORAGE EQUIPMENT MARKET SIZE, BY BLOOD BANKS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL BLOOD STORAGE EQUIPMENT MARKET SIZE, BY BLOOD BANKS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL BLOOD STORAGE EQUIPMENT MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL BLOOD STORAGE EQUIPMENT MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL BLOOD STORAGE EQUIPMENT MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL BLOOD STORAGE EQUIPMENT MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL BLOOD STORAGE EQUIPMENT MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL BLOOD STORAGE EQUIPMENT MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL BLOOD STORAGE EQUIPMENT MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL BLOOD STORAGE EQUIPMENT MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL BLOOD STORAGE EQUIPMENT MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL BLOOD STORAGE EQUIPMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 59. AMERICAS BLOOD STORAGE EQUIPMENT MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 60. AMERICAS BLOOD STORAGE EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 61. AMERICAS BLOOD STORAGE EQUIPMENT MARKET SIZE, BY STORAGE MODE, 2018-2032 (USD MILLION)
  • TABLE 62. AMERICAS BLOOD STORAGE EQUIPMENT MARKET SIZE, BY CRYOGENIC STORAGE, 2018-2032 (USD MILLION)
  • TABLE 63. AMERICAS BLOOD STORAGE EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 64. AMERICAS BLOOD STORAGE EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 65. NORTH AMERICA BLOOD STORAGE EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. NORTH AMERICA BLOOD STORAGE EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 67. NORTH AMERICA BLOOD STORAGE EQUIPMENT MARKET SIZE, BY STORAGE MODE, 2018-2032 (USD MILLION)
  • TABLE 68. NORTH AMERICA BLOOD STORAGE EQUIPMENT MARKET SIZE, BY CRYOGENIC STORAGE, 2018-2032 (USD MILLION)
  • TABLE 69. NORTH AMERICA BLOOD STORAGE EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 70. NORTH AMERICA BLOOD STORAGE EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 71. LATIN AMERICA BLOOD STORAGE EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. LATIN AMERICA BLOOD STORAGE EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 73. LATIN AMERICA BLOOD STORAGE EQUIPMENT MARKET SIZE, BY STORAGE MODE, 2018-2032 (USD MILLION)
  • TABLE 74. LATIN AMERICA BLOOD STORAGE EQUIPMENT MARKET SIZE, BY CRYOGENIC STORAGE, 2018-2032 (USD MILLION)
  • TABLE 75. LATIN AMERICA BLOOD STORAGE EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 76. LATIN AMERICA BLOOD STORAGE EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 77. EUROPE, MIDDLE EAST & AFRICA BLOOD STORAGE EQUIPMENT MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 78. EUROPE, MIDDLE EAST & AFRICA BLOOD STORAGE EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 79. EUROPE, MIDDLE EAST & AFRICA BLOOD STORAGE EQUIPMENT MARKET SIZE, BY STORAGE MODE, 2018-2032 (USD MILLION)
  • TABLE 80. EUROPE, MIDDLE EAST & AFRICA BLOOD STORAGE EQUIPMENT MARKET SIZE, BY CRYOGENIC STORAGE, 2018-2032 (USD MILLION)
  • TABLE 81. EUROPE, MIDDLE EAST & AFRICA BLOOD STORAGE EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 82. EUROPE, MIDDLE EAST & AFRICA BLOOD STORAGE EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 83. EUROPE BLOOD STORAGE EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 84. EUROPE BLOOD STORAGE EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 85. EUROPE BLOOD STORAGE EQUIPMENT MARKET SIZE, BY STORAGE MODE, 2018-2032 (USD MILLION)
  • TABLE 86. EUROPE BLOOD STORAGE EQUIPMENT MARKET SIZE, BY CRYOGENIC STORAGE, 2018-2032 (USD MILLION)
  • TABLE 87. EUROPE BLOOD STORAGE EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 88. EUROPE BLOOD STORAGE EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 89. MIDDLE EAST BLOOD STORAGE EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 90. MIDDLE EAST BLOOD STORAGE EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 91. MIDDLE EAST BLOOD STORAGE EQUIPMENT MARKET SIZE, BY STORAGE MODE, 2018-2032 (USD MILLION)
  • TABLE 92. MIDDLE EAST BLOOD STORAGE EQUIPMENT MARKET SIZE, BY CRYOGENIC STORAGE, 2018-2032 (USD MILLION)
  • TABLE 93. MIDDLE EAST BLOOD STORAGE EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 94. MIDDLE EAST BLOOD STORAGE EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 95. AFRICA BLOOD STORAGE EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 96. AFRICA BLOOD STORAGE EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 97. AFRICA BLOOD STORAGE EQUIPMENT MARKET SIZE, BY STORAGE MODE, 2018-2032 (USD MILLION)
  • TABLE 98. AFRICA BLOOD STORAGE EQUIPMENT MARKET SIZE, BY CRYOGENIC STORAGE, 2018-2032 (USD MILLION)
  • TABLE 99. AFRICA BLOOD STORAGE EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 100. AFRICA BLOOD STORAGE EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 101. ASIA-PACIFIC BLOOD STORAGE EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 102. ASIA-PACIFIC BLOOD STORAGE EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 103. ASIA-PACIFIC BLOOD STORAGE EQUIPMENT MARKET SIZE, BY STORAGE MODE, 2018-2032 (USD MILLION)
  • TABLE 104. ASIA-PACIFIC BLOOD STORAGE EQUIPMENT MARKET SIZE, BY CRYOGENIC STORAGE, 2018-2032 (USD MILLION)
  • TABLE 105. ASIA-PACIFIC BLOOD STORAGE EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 106. ASIA-PACIFIC BLOOD STORAGE EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL BLOOD STORAGE EQUIPMENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 108. ASEAN BLOOD STORAGE EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 109. ASEAN BLOOD STORAGE EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 110. ASEAN BLOOD STORAGE EQUIPMENT MARKET SIZE, BY STORAGE MODE, 2018-2032 (USD MILLION)
  • TABLE 111. ASEAN BLOOD STORAGE EQUIPMENT MARKET SIZE, BY CRYOGENIC STORAGE, 2018-2032 (USD MILLION)
  • TABLE 112. ASEAN BLOOD STORAGE EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 113. ASEAN BLOOD STORAGE EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 114. GCC BLOOD STORAGE EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 115. GCC BLOOD STORAGE EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 116. GCC BLOOD STORAGE EQUIPMENT MARKET SIZE, BY STORAGE MODE, 2018-2032 (USD MILLION)
  • TABLE 117. GCC BLOOD STORAGE EQUIPMENT MARKET SIZE, BY CRYOGENIC STORAGE, 2018-2032 (USD MILLION)
  • TABLE 118. GCC BLOOD STORAGE EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 119. GCC BLOOD STORAGE EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 120. EUROPEAN UNION BLOOD STORAGE EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 121. EUROPEAN UNION BLOOD STORAGE EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 122. EUROPEAN UNION BLOOD STORAGE EQUIPMENT MARKET SIZE, BY STORAGE MODE, 2018-2032 (USD MILLION)
  • TABLE 123. EUROPEAN UNION BLOOD STORAGE EQUIPMENT MARKET SIZE, BY CRYOGENIC STORAGE, 2018-2032 (USD MILLION)
  • TABLE 124. EUROPEAN UNION BLOOD STORAGE EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 125. EUROPEAN UNION BLOOD STORAGE EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 126. BRICS BLOOD STORAGE EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 127. BRICS BLOOD STORAGE EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 128. BRICS BLOOD STORAGE EQUIPMENT MARKET SIZE, BY STORAGE MODE, 2018-2032 (USD MILLION)
  • TABLE 129. BRICS BLOOD STORAGE EQUIPMENT MARKET SIZE, BY CRYOGENIC STORAGE, 2018-2032 (USD MILLION)
  • TABLE 130. BRICS BLOOD STORAGE EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 131. BRICS BLOOD STORAGE EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 132. G7 BLOOD STORAGE EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 133. G7 BLOOD STORAGE EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 134. G7 BLOOD STORAGE EQUIPMENT MARKET SIZE, BY STORAGE MODE, 2018-2032 (USD MILLION)
  • TABLE 135. G7 BLOOD STORAGE EQUIPMENT MARKET SIZE, BY CRYOGENIC STORAGE, 2018-2032 (USD MILLION)
  • TABLE 136. G7 BLOOD STORAGE EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 137. G7 BLOOD STORAGE EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 138. NATO BLOOD STORAGE EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 139. NATO BLOOD STORAGE EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 140. NATO BLOOD STORAGE EQUIPMENT MARKET SIZE, BY STORAGE MODE, 2018-2032 (USD MILLION)
  • TABLE 141. NATO BLOOD STORAGE EQUIPMENT MARKET SIZE, BY CRYOGENIC STORAGE, 2018-2032 (USD MILLION)
  • TABLE 142. NATO BLOOD STORAGE EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 143. NATO BLOOD STORAGE EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 144. GLOBAL BLOOD STORAGE EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 145. UNITED STATES BLOOD STORAGE EQUIPMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 146. UNITED STATES BLOOD STORAGE EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 147. UNITED STATES BLOOD STORAGE EQUIPMENT MARKET SIZE, BY STORAGE MODE, 2018-2032 (USD MILLION)
  • TABLE 148. UNITED STATES BLOOD STORAGE EQUIPMENT MARKET SIZE, BY CRYOGENIC STORAGE, 2018-2032 (USD MILLION)
  • TABLE 149. UNITED STATES BLOOD STORAGE EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 150. UNITED STATES BLOOD STORAGE EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 151. CHINA BLOOD STORAGE EQUIPMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 152. CHINA BLOOD STORAGE EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 153. CHINA BLOOD STORAGE EQUIPMENT MARKET SIZE, BY STORAGE MODE, 2018-2032 (USD MILLION)
  • TABLE 154. CHINA BLOOD STORAGE EQUIPMENT MARKET SIZE, BY CRYOGENIC STORAGE, 2018-2032 (USD MILLION)
  • TABLE 155. CHINA BLOOD STORAGE EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 156. CHINA BLOOD STORAGE EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)